Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
暂无分享,去创建一个
[1] A. Henney,et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] Y. Sasaguri,et al. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. , 1991, Atherosclerosis.
[3] J. McEwan,et al. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. , 1999, Circulation.
[4] S. Kaul,et al. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. , 1999, Circulation.
[5] M. Davies. The pathophysiology of acute coronary syndromes , 2000, Indian heart journal.
[6] S. Weiss,et al. Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. , 2001, Journal of vascular surgery.
[7] P. Libby,et al. An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro , 2001, Circulation.
[8] A. Clowes,et al. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. , 1997, Circulation research.
[9] A. Newby,et al. Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[10] B. Strauss,et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. , 1996, Circulation research.
[11] F. Soubrier,et al. Clinical implications of the molecular biology of the renin-angiotensin system. , 1990, European heart journal.
[12] P. Libby,et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. , 1998, The American journal of pathology.
[13] WolfgangKoenig,et al. Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease , 2003 .
[14] P. Libby,et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? , 1997, Circulation research.
[15] É. Allaire,et al. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.
[16] S E Nissen,et al. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study. , 2000, Circulation.
[17] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[18] Jason L Johnson,et al. Characteristics of Intact and Ruptured Atherosclerotic Plaques in Brachiocephalic Arteries of Apolipoprotein E Knockout Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[19] K. Siddle,et al. Defect in Insulin-Like Growth Factor-1 Survival Mechanism in Atherosclerotic Plaque-Derived Vascular Smooth Muscle Cells Is Mediated by Reduced Surface Binding and Signaling , 2001, Circulation research.
[20] M. Davies,et al. Upregulation of basement membrane-degrading metalloproteinase secretion after balloon injury of pig carotid arteries. , 1996, Circulation research.
[21] M. Ferguson,et al. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. , 1996, The American journal of pathology.
[22] S. Shapiro,et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.
[23] M. Aoyagi,et al. Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation , 1998, Histochemistry and Cell Biology.
[24] M. Ferguson,et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.
[25] V. Fuster,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. , 1995, Circulation.
[26] J. K. Lee,et al. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. , 1999, Biochemical and biophysical research communications.
[27] A. Baker,et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.
[28] A. Newby. Vitronectin is implicated as the matrix takes control of neointima formation. , 2002, Cardiovascular research.
[29] D. Reed,et al. Are Aortic Aneurysms Caused by Atherosclerosis? , 1992, Circulation.
[30] S. Shapiro,et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Barbacid,et al. Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3* , 1997, The Journal of Biological Chemistry.
[32] P. Wolters,et al. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. , 1999, Journal of immunology.
[33] P. Libby,et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. , 1998, Journal of the American College of Cardiology.
[34] M. Jeune,et al. Enhanced Expression of Matrix Metalloproteinase‐3, ‐12, and ‐13 mRNAs in the Aortas of Apolipoprotein E‐deficient Mice with Advanced Atherosclerosis , 1999, Annals of the New York Academy of Sciences.
[35] A. Newby,et al. Gene Therapy for All Aspects of Vein‐Graft Disease , 2002, Journal of cardiac surgery.
[36] D. Woolley,et al. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries , 1999, The Journal of pathology.
[37] C. Napoli,et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E‐deficient and LDL receptor‐deficient mice , 2001, The Journal of pathology.
[38] A. Baker,et al. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins , 1998, Gene Therapy.
[39] A. Evans,et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. , 1999, Circulation.
[40] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[41] T. Ley,et al. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Jackson,et al. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors. , 2002, Cardiovascular research.
[43] A. Cho,et al. Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury , 2002, Circulation research.
[44] W. Parks,et al. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. , 2000, Gene.
[45] C. López-Otín,et al. Differential Effects of Transforming Growth Factor-β on the Expression of Collagenase-1 and Collagenase-3 in Human Fibroblasts* , 1998, The Journal of Biological Chemistry.
[46] E. Nabel,et al. Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.
[47] Z. Galis,et al. Expansive Arterial Remodeling Is Associated With Increased Neointimal Macrophage Foam Cell Content: The Murine Model of Macrophage-Rich Carotid Artery Lesions , 2002, Circulation.
[48] F. Cambien,et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease , 2003, Circulation.
[49] G. Amorino,et al. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. , 1998, The American journal of pathology.
[50] P. Thorén,et al. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[51] W. Pearce,et al. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[52] P. Slocombe,et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. , 1998, FEBS letters.
[53] E. Nabel,et al. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. , 2000, Circulation.
[54] W. Koenig,et al. Antidiabetic PPAR&ggr;-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease , 2003 .
[55] H. Lijnen,et al. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. , 1999, Circulation research.
[56] Julie H. Campbell,et al. Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. , 1990, The Biochemical journal.
[57] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[58] M. Crow,et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. , 1998, Circulation.
[59] S. Schwartz,et al. Monoclonality of smooth muscle cells in human atherosclerosis. , 1997, The American journal of pathology.
[60] T. Ugarova,et al. Differential Induction of Gelatinase B (MMP-9) and Gelatinase A (MMP-2) in T Lymphocytes upon α4β1-Mediated Adhesion to VCAM-1 and the CS-1 Peptide of Fibronectin☆ , 2000 .
[61] T. Haas,et al. Three-dimensional Type I Collagen Lattices Induce Coordinate Expression of Matrix Metalloproteinases MT1-MMP and MMP-2 in Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[62] A. Zalewski,et al. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[63] D. Cheresh,et al. Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.
[64] S. Schwartz,et al. Significance of Quiescent Smooth Muscle Migration in the Injured Rat Carotid Artery , 1985, Circulation research.
[65] WulfPalinski,et al. Unraveling Pleiotropic Effects of Statins on Plaque Rupture , 2002 .
[66] Y. Okada,et al. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.
[67] J. Chamley-Campbell,et al. What controls smooth muscle phenotype? , 1981, Atherosclerosis.
[68] X. Han,et al. Transcriptional Up-regulation of Endothelial Cell Matrix Metalloproteinase-2 in Response to Extracellular Cues Involves GATA-2* , 2003, Journal of Biological Chemistry.
[69] R. Timpl. Macromolecular organization of basement membranes. , 1996, Current opinion in cell biology.
[70] B. Paigen,et al. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. , 1990, Arteriosclerosis.
[71] Peter Tontonoz,et al. Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in Macrophages* , 2003, The Journal of Biological Chemistry.
[72] R. Virmani,et al. Histopathologic analysis of in‐stent neointimal regression in a porcine coronary model , 2000, Coronary artery disease.
[73] S. George,et al. Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[74] Steven M. Holland,et al. Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase‐2 (MMP‐2) via NAD(P)H Oxidase‐Derived Reactive Oxygen Species , 2003, Circulation research.
[75] M. Hollenberg,et al. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. , 2001, The Biochemical journal.
[76] D. Bowyer,et al. A standardised method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. , 1991, Atherosclerosis.
[77] J. McEwan,et al. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[78] E. Lakatta,et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. , 1996, The American journal of pathology.
[79] B. Sumpio,et al. Transcription Factor Sp1 Phosphorylation Induced by Shear Stress Inhibits Membrane Type 1-Matrix Metalloproteinase Expression in Endothelium* , 2002, The Journal of Biological Chemistry.
[80] F. Lupu,et al. Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[81] E. Fleck,et al. Endoproteolytic Activation of &agr;v Integrin by Proprotein Convertase PC5 Is Required for Vascular Smooth Muscle Cell Adhesion to Vitronectin and Integrin-Dependent Signaling , 2004, Circulation.
[82] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[83] C. Brinckerhoff,et al. The AP-1 site and MMP gene regulation: what is all the fuss about? , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[84] G. Angelini,et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits SMC migration and neointima formation in human saphenous vein , 1998 .
[85] M. Pepper. Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[86] J. Liao,et al. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[87] F J Schoen,et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[88] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[89] U. Ikeda,et al. Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. , 2000, Journal of cardiovascular pharmacology.
[90] U. Ikeda,et al. Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. , 2000, Journal of molecular and cellular cardiology.
[91] M. Bennett,et al. IN-STENT STENOSIS: PATHOLOGY AND IMPLICATIONS FOR THE DEVELOPMENT OF DRUG ELUTING STENTS , 2003, Heart.
[92] Y. Okada,et al. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. , 1999, European journal of biochemistry.
[93] F. Bernini,et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[94] J. Berger,et al. Activation of PPARα or γ Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 Cells , 2000 .
[95] M. Reidy,et al. The Role of Plasminogen Activation in Smooth Muscle Cell Migration after Arterial Injury , 1992, Annals of the New York Academy of Sciences.
[96] E. Lakatta,et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. , 1994, Circulation research.
[97] M. Makuuchi,et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.
[98] A. Borczuk,et al. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. , 2001, The Journal of clinical investigation.
[99] A. Newby,et al. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. , 1996, The Biochemical journal.
[100] H. Klocker,et al. Androgen Receptor-Ets Protein Interaction Is a Novel Mechanism for Steroid Hormone-mediated Down-modulation of Matrix Metalloproteinase Expression* , 1996, The Journal of Biological Chemistry.
[101] V. V. van Hinsbergh,et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.
[102] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[103] A. Zalewski,et al. Diverse Origin of Intimal Cells: Smooth Muscle Cells, Myofibroblasts, Fibroblasts, and Beyond? , 2002, Circulation research.
[104] C. Soria,et al. Activation of the 92 kDa type IV collagenase by tissue kallikrein , 1993, Journal of cellular physiology.
[105] A. Newby,et al. Monocyte adhesion to human saphenous vein in vitro. , 1991, Atherosclerosis.
[106] H. Mühl,et al. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNFα blockage and modulation by IL-10 , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[107] Stephen M. Schwartz,et al. Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[108] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[109] D. Collen,et al. Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene , 2002, Circulation research.
[110] James P. Quigley,et al. Matrix Metalloproteinase-2 Is an Interstitial Collagenase , 1995, The Journal of Biological Chemistry.
[111] A. Morgan,et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease , 2003, Journal of Molecular Medicine.
[112] E. P. Moiseeva. Adhesion receptors of vascular smooth muscle cells and their functions. , 2001, Cardiovascular research.
[113] Giulio Gabbiani,et al. Arterial Smooth Muscle Cell Heterogeneity: Implications for Atherosclerosis and Restenosis Development , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[114] M. Shibata,et al. Apoptotic detection methods--from morphology to gene. , 2003, Progress in histochemistry and cytochemistry.
[115] A. Clowes,et al. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[116] M. Ferguson,et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. , 1995, Circulation.
[117] D. Woolley,et al. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. , 1994, European journal of biochemistry.
[118] T. Shofuda,et al. Cleavage of Focal Adhesion Kinase in Vascular Smooth Muscle Cells Overexpressing Membrane-Type Matrix Metalloproteinases , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[119] J. Campbell,et al. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. , 1985, Experimental and molecular pathology.
[120] J. Campbell,et al. Culture techniques and their applications to studies of vascular smooth muscle. , 1993, Clinical science.
[121] J. McEwan,et al. TIMP‐4 Is Regulated by Vascular Injury in Rats , 1999, Circulation research.
[122] A M Zeiher,et al. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. , 2000, Circulation research.
[123] R. Dilley,et al. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. , 1988, Archives of surgery.
[124] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[125] M. Jeune,et al. Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury , 1999, Annals of the New York Academy of Sciences.
[126] Z. Galis,et al. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[127] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[128] B Hillen,et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. , 1998, Journal of the American College of Cardiology.
[129] M J Davies,et al. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.
[130] M. Weiser-Evans,et al. Changes in Perlecan Expression During Vascular Injury: Role in the Inhibition of Smooth Muscle Cell Proliferation in the Late Lesion , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[131] P. Carmeliet,et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. , 1997, Circulation research.
[132] R. Huber,et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.
[133] R. Stoney,et al. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[134] A. Zalewski,et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. , 1996, Circulation.
[135] S. Itohara,et al. Deficiency of Gelatinase A Suppresses Smooth Muscle Cell Invasion and Development of Experimental Intimal Hyperplasia , 2003, Circulation.
[136] Z. Galis,et al. Expression of Matrix Metalloproteinase-9 in Endothelial Cells Is Differentially Regulated by Shear Stress , 2003, Journal of Biological Chemistry.
[137] G. Cherr,et al. Metalloproteinase Inhibition and the Response to Angioplasty and Stenting in Atherosclerotic Primates , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[138] Julie H. Campbell,et al. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo. , 1998, Journal of vascular surgery.
[139] A. Clowes,et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.
[140] Carol Cass,et al. Nitric Oxide and Cyclic GMP Increase the Expression of Matrix Metalloproteinase-9 in Vascular Smooth Muscle , 2003, Journal of Pharmacology and Experimental Therapeutics.
[141] M. Reidy,et al. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. , 1996, Circulation research.
[142] G. Zhou,et al. Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. , 2000, Biochemical and biophysical research communications.
[143] Y. Nagashima,et al. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[144] A. Henney,et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. , 1994, British heart journal.
[145] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[146] Jiankun Cui,et al. S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.
[147] S. George,et al. Formation in Organ Cultures of Human Saphenous Vein Expression of Tissue Inhibitor of Metalloproteinase-1 ,2 , and-3 During Neointima , 1999 .
[148] J. Blankensteijn,et al. Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model. , 2004, Journal of vascular surgery.
[149] D. Nance,et al. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. , 1995, The Journal of clinical investigation.
[150] R. Ross,et al. Atherosclerosis and the Arterial Smooth Muscle Cell , 1973 .
[151] J. Isner,et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.
[152] M. Reidy,et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.
[153] G. Angelini,et al. The future of saphenous vein as a coronary artery bypass conduit. , 1989, European heart journal.
[154] P. Libby,et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.
[155] E. Stringa,et al. Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells. , 2000, Journal of cell science.
[156] Z. Galis,et al. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? , 1998, Circulation.
[157] A. Gotlieb,et al. Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. , 1989, The American journal of pathology.
[158] A. Woods,et al. Syndecan proteoglycans and cell adhesion. , 1998, Matrix biology : journal of the International Society for Matrix Biology.
[159] Jason L. Johnson,et al. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. , 2001, Atherosclerosis.
[160] C. Brinckerhoff,et al. Induction of collagenase and stromelysin gene expression by mechanical injury in a vascular smooth muscle‐derived cell line , 1993, Journal of cellular physiology.
[161] L. Petit,et al. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. , 1999, Circulation.
[162] G. Angelini,et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. , 1998, Human gene therapy.
[163] K. Schrör,et al. Factor Xa Releases Matrix Metalloproteinase-2 (MMP-2) From Human Vascular Smooth Muscle Cells and Stimulates the Conversion of Pro–MMP-2 to MMP-2: Role of MMP-2 in Factor Xa–Induced DNA Synthesis and Matrix Invasion , 2002, Circulation research.
[164] A. Daugherty,et al. Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II–Induced Atherosclerosis and Abdominal Aortic Aneurysms , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[165] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[166] N. Nakajima,et al. Cyclic Strain Stimulates Early Growth Response Gene Product 1–Mediated Expression of Membrane Type 1 Matrix Metalloproteinase in Endothelium , 2002, Laboratory Investigation.
[167] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[168] M. Bennett,et al. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. , 2001, Pharmacology & therapeutics.
[169] A. Clowes,et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. , 1999, Circulation research.
[170] A. Newby,et al. Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB , 1998, FEBS letters.
[171] C. Shanahan,et al. Vascular Extracellular Matrix , 2002 .
[172] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[173] H. Lijnen,et al. Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[174] P. Weissberg,et al. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. , 1993, Cardiovascular research.
[175] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[176] J. Mehta,et al. LOX-1 Mediates Oxidized Low-Density Lipoprotein-Induced Expression of Matrix Metalloproteinases in Human Coronary Artery Endothelial Cells , 2003, Circulation.
[177] R. Ross,et al. Expression of a disintegrin‐like protein in cultured human vascular cells and in vivo , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[178] R. Ross,et al. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. , 1973, Science.
[179] M J Davies,et al. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.
[180] H. Birkedal‐Hansen,et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[181] E. Benditt,et al. Evidence for a monoclonal origin of human atherosclerotic plaques. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[182] R. Béliveau,et al. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. , 2002, Journal of vascular surgery.
[183] P. Libby,et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[184] P. Libby,et al. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[185] Jianglin Fan,et al. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[186] J. Gunn,et al. Apoptosis and cell proliferation after porcine coronary angioplasty. , 1998, Circulation.
[187] D. Belin,et al. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. , 1990, Circulation research.
[188] A. Newby,et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. , 2001, Cardiovascular research.
[189] R. Natarajan,et al. Diabetes-induced accelerated atherosclerosis in swine. , 2001, Diabetes.
[190] J. Thyberg,et al. The Synthetic Metalloproteinase Inhibitor Batimastat Suppresses Injury-Induced Phosphorylation of MAP Kinase ERK1/ERK2 and Phenotypic Modification of Arterial Smooth Muscle Cells in vitro , 2000, Journal of Vascular Research.
[191] P. Libby,et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.
[192] E. Topol,et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.
[193] A. Weyrich,et al. Differential Regulation of Matrix Metalloproteinase-9 by Monocytes Adherent to Collagen and Platelets , 2001, Circulation research.
[194] S. George,et al. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. , 1993, Cardiovascular research.
[195] J. Thyberg. Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. , 1998, Histology and histopathology.
[196] Qingbo Xu,et al. Mouse model of venous bypass graft arteriosclerosis. , 1998, The American journal of pathology.
[197] P. Libby,et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. , 1998, Circulation research.
[198] J. Thyberg,et al. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.
[199] Jason L Johnson,et al. 3HT03-3 Matrix metalloproteinases-9 and -12 have opposite effects on atherosclerotic plaque stability , 2003 .
[200] P R Bell,et al. Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.
[201] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[202] E. Tuzcu,et al. Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. , 2002, The American journal of cardiology.
[203] P. Libby,et al. Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma: A Novel Collagenolytic Pathway Suggested by Transcriptional Profiling , 2001, Circulation.
[204] J. Pickering,et al. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[205] M. Rekhter. How to evaluate plaque vulnerability in animal models of atherosclerosis? , 2002, Cardiovascular research.
[206] G. Angelini,et al. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[207] P. Libby,et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. , 1999, The American journal of pathology.
[208] J. Thyberg,et al. Phenotypic Modulation of Smooth Muscle Cells after Arterial Injury Is Associated with Changes in the Distribution of Laminin and Fibronectin , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[209] J. Skepper,et al. Acetylated Low-Density Lipoprotein Stimulates Human Vascular Smooth Muscle Cell Calcification by Promoting Osteoblastic Differentiation and Inhibiting Phagocytosis , 2002, Circulation.
[210] W. Parks,et al. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. , 1995, Journal of immunology.
[211] A. Naylor,et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. , 2000, Stroke.
[212] P. Libby,et al. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[213] D. Yue,et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. , 2003, Atherosclerosis.
[214] D. Courtman,et al. A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening. , 2003, The American journal of pathology.
[215] T. Wight,et al. The extracellular matrix and atherosclerosis , 1995, Current opinion in lipidology.
[216] James M. Roberts,et al. Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors , 1996, Cell.
[217] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[218] C. Glass,et al. The peroxisome proliferator‐activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function , 1999 .
[219] Alex Y Strongin,et al. An Alternative Processing of Integrin αv Subunit in Tumor Cells by Membrane Type-1 Matrix Metalloproteinase* , 2002, The Journal of Biological Chemistry.
[220] J. Quigley,et al. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. , 1995, The Journal of biological chemistry.
[221] P. Libby,et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. , 1998, Circulation.
[222] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[223] G. Angelini,et al. Intimal proliferation in an organ culture of human saphenous vein. , 1990, The American journal of pathology.
[224] P. Libby,et al. Stabilization of atherosclerotic plaques: New mechanisms and clinical targets , 2002, Nature Medicine.
[225] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[226] Hong Wang,et al. Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in Macrophages* , 2000, The Journal of Biological Chemistry.
[227] G. Angelini,et al. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. , 2000, Circulation.
[228] Z. Galis,et al. Remodeling of Carotid Artery Is Associated With Increased Expression of Matrix Metalloproteinases in Mouse Blood Flow Cessation Model , 2000, Circulation.
[229] R. Khokha,et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.
[230] T. Watanabe,et al. Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages. , 2000, Biochemical and biophysical research communications.
[231] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[232] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[233] J. Powell,et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[234] R. Pruett,et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy , 1994, Nature Genetics.
[235] B. Perler. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms , 1993 .
[236] P. Carmeliet,et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation , 1997, Nature Genetics.
[237] R. Black. Tumor necrosis factor-alpha converting enzyme. , 2002, The international journal of biochemistry & cell biology.
[238] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[239] S. Kawashima,et al. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. , 2001, Atherosclerosis.
[240] A. von Eckardstein,et al. Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist? , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[241] Yan Huang,et al. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[242] Jason L. Johnson,et al. Relationship between type IV collagen degradation, metalloproteinase activity and smooth muscle cell migration and proliferation in cultured human saphenous vein. , 2003, Cardiovascular research.
[243] QingboXu,et al. Both Donor and Recipient Origins of Smooth Muscle Cells in Vein Graft Atherosclerotic Lesions , 2002 .
[244] A. Clowes,et al. Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. , 1992, Circulation research.
[245] M. Schwartz,et al. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. , 2001, Journal of cell science.
[246] M. Reidy,et al. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[247] J. Thyberg. Differentiated properties and proliferation of arterial smooth muscle cells in culture. , 1996, International review of cytology.
[248] Z. Galis,et al. Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling , 2002, Circulation research.
[249] S. Kaul,et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. , 1999, Circulation.
[250] B. Strauss,et al. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. , 2002, The American journal of pathology.
[251] G. Angelini,et al. Dismantling of Cadherin-Mediated Cell-Cell Contacts Modulates Smooth Muscle Cell Proliferation , 2003, Circulation research.
[252] J. Thyberg,et al. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. , 1989, Developmental biology.
[253] Timothy C Greiner,et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.
[254] G. Angelini,et al. Injury Induces Dedifferentiation of Smooth Muscle Cells and Increased Matrix-Degrading Metalloproteinase Activity in Human Saphenous Vein , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[255] W. Edwards,et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[256] D. Edwards,et al. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). , 2003, The Biochemical journal.
[257] Danny L Wang,et al. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells. , 2004, Molecular pharmacology.
[258] Brian J. Bennett,et al. Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[259] Young-Choon Lee,et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. , 2003, Biochemical and biophysical research communications.
[260] P. Carmeliet,et al. Temporal and Topographic Matrix Metalloproteinase Expression after Vascular Injury in Mice , 1999, Thrombosis and Haemostasis.
[261] R. Virmani,et al. Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.
[262] K. Channon,et al. Nitric Oxide Synthase (nNOS) Gene Transfer Modifies Venous Bypass Graft Remodeling: Effects on Vascular Smooth Muscle Cell Differentiation and Superoxide Production , 2001, Circulation.
[263] François Mach,et al. Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In Vivo , 1999, The Journal of experimental medicine.
[264] P. Libby,et al. Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. , 1998, Circulation research.
[265] M. Leon,et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. , 1996, Circulation.
[266] H. Schaff,et al. Gene therapy for vein graft disease , 2001, Current cardiology reports.
[267] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[268] C von Birgelen,et al. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. , 1995, The American journal of cardiology.
[269] M. Davies,et al. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. , 1991, Atherosclerosis.
[270] Z. Galis,et al. Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[271] A. Newby,et al. Regulation of Matrix Metalloproteinase (Matrixin) Genes in Blood Vessels: A Multi-Step Recruitment Model for Pathological Remodelling , 2003, Journal of Vascular Research.
[272] B. Strauss,et al. Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor. , 2002, Journal of the American College of Cardiology.
[273] V. Ellis. Plasminogen activation at the cell surface. , 2003, Current topics in developmental biology.
[274] R. Hershkoviz,et al. Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-α1 , 2001, The Journal of Immunology.
[275] J. Soulillou,et al. Antigraft Antibody-Mediated Expression of Metalloproteinases on Endothelial Cells: Differential Expression of TIMP-1 and ADAM-10 Depends on Antibody Specificity and Isotype , 2001, Circulation research.
[276] A. Newby,et al. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. , 1997, Atherosclerosis.
[277] J. D’Armiento,et al. Increased Medial Degradation With Pseudo-Aneurysm Formation in Apolipoprotein E–Knockout Mice Deficient in Tissue Inhibitor of Metalloproteinases-1 , 2003, Circulation.
[278] Michiko Watanabe,et al. The Pros and Cons of Apoptosis Assays for Use in the Study of Cells, Tissues, and Organs , 2002, Microscopy and Microanalysis.
[279] E. Topol,et al. Strategies to achieve coronary arterial plaque stabilization. , 1999, Cardiovascular research.
[280] H. C. Stary,et al. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. , 1990, European heart journal.
[281] P. Libby,et al. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. , 1991, The American journal of pathology.
[282] B. Staels,et al. Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[283] H. Nagase,et al. MMPs Are IGFBP‐Degrading Proteinases: Implications for Cell Proliferation and Tissue Growth , 1999, Annals of the New York Academy of Sciences.
[284] A. Strongin,et al. Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-αv integrin regulates cross-talk between αvβ3 and α2β1 integrinsin breast carcinoma cells , 2003 .
[285] A. Clowes,et al. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. , 1994, The Journal of clinical investigation.
[286] J. Lettieri,et al. LC separation and induced fluorometric detection of rivastatin in blood plasma. , 1993, Journal of pharmaceutical and biomedical analysis.
[287] S. Kaul,et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. , 1999, Circulation.
[288] J. Deux,et al. Differential Expression of Matrix Metalloproteinases After Stent Implantation and Balloon Angioplasty in the Hypercholesterolemic Rabbit , 2001, Circulation.
[289] L. Claesson‐Welsh,et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.
[290] J. Caillaud,et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. , 1999, Circulation.
[291] Membrane type-1 matrix metalloproteinase (MT1-MMP) processing of pro-alphav integrin regulates cross-talk between alphavbeta3 and alpha2beta1 integrins in breast carcinoma cells. , 2003, Experimental cell research.
[292] A. Baker,et al. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. , 1999, Biochemical and biophysical research communications.
[293] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[294] B. Baxter,et al. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. , 2003, Journal of vascular surgery.
[295] A. Newby,et al. Role of Nuclear Factor-&kgr;B Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[296] L. Lin,et al. Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. , 1995, The American journal of pathology.
[297] K. Sobue,et al. Differentiated Phenotype of Smooth Muscle Cells Depends on Signaling Pathways through Insulin-like Growth Factors and Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.
[298] S. George,et al. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. , 1997, Cardiovascular research.
[299] Federico Castro-Muñozledo,et al. Commitment of 3T3-F442A cells to adipocyte differentiation takes place during the first 24-36 h after adipogenic stimulation: TNF-alpha inhibits commitment. , 2003, Experimental cell research.
[300] Y. Sasaguri,et al. A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. , 1998, Atherosclerosis.
[301] P. Carmeliet. Proteinases in cardiovascular aneurysms and rupture: targets for therapy? , 2000, The Journal of clinical investigation.
[302] B. Baxter,et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. , 2002, Journal of vascular surgery.
[303] A. Luttun,et al. Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.
[304] P. Shah,et al. Increased Expression of Membrane Type 3-Matrix Metalloproteinase in Human Atherosclerotic Plaque: Role of Activated Macrophages and Inflammatory Cytokines , 2002, Circulation.
[305] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[306] P. Libby,et al. Sustained Activation of Vascular Cells and Leukocytes in the Rabbit Aorta After Balloon Injury , 1993, Circulation.
[307] P. Libby,et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. , 1997, Circulation.
[308] A. Newby,et al. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. , 1992, The Biochemical journal.
[309] H. Nagase,et al. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[310] H. Lijnen. Plasmin and Matrix Metalloproteinases in Vascular Remodeling , 2001, Thrombosis and Haemostasis.
[311] M. Reidy,et al. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. , 1994, Journal of vascular surgery.
[312] J. Verheijen,et al. Angioplasty : A Study in the Atherosclerotic Yucatan Micropig Metalloproteinase Inhibition Reduces Constrictive Arterial Remodeling After Balloon , 2000 .
[313] P. Kovanen,et al. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. , 1996, Journal of immunology.
[314] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[315] V. Kähäri,et al. Matrix metalloproteinases in skin , 1997, Experimental dermatology.
[316] P. Kiener,et al. Activation of human monocytes through CD40 induces matrix metalloproteinases. , 1996, Journal of immunology.